Compile Data Set for Download or QSAR
maximum 50k data
Found 27 Enz. Inhib. hit(s) with all data for entry = 7049
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169633(US9079906, 117)
Affinity DataIC50:  98nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169631(US9079906, 89)
Affinity DataIC50:  107nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169650(US9079906, 239)
Affinity DataIC50:  113nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169641(US9079906, 186)
Affinity DataIC50:  119nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169640(US9079906, 178)
Affinity DataIC50:  126nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169642(US9079906, 197)
Affinity DataIC50:  149nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169646(US9079906, 221)
Affinity DataIC50:  155nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169644(US9079906, 207)
Affinity DataIC50:  174nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169639(US9079906, 174)
Affinity DataIC50:  183nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169643(US9079906, 199)
Affinity DataIC50:  206nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169645(US9079906, 215)
Affinity DataIC50:  219nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169648(US9079906, 230)
Affinity DataIC50:  234nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169638(US9079906, 168)
Affinity DataIC50:  257nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169625(US9079906, 14)
Affinity DataIC50:  279nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169637(US9079906, 163)
Affinity DataIC50:  364nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169636(US9079906, 161)
Affinity DataIC50:  365nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169647(US9079906, 222)
Affinity DataIC50:  416nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169651(US9079906, 240)
Affinity DataIC50:  484nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169627(US9079906, 50)
Affinity DataIC50:  631nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169635(US9079906, 144)
Affinity DataIC50:  827nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169629(US9079906, 76)
Affinity DataIC50:  951nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169626(US9079906, 26)
Affinity DataIC50:  1.10E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169632(US9079906, 101)
Affinity DataIC50:  1.40E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169649(US9079906, 236)
Affinity DataIC50:  1.40E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169634(US9079906, 127)
Affinity DataIC50:  2.50E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169630(US9079906, 84)
Affinity DataIC50:  9.80E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM169628(US9079906, 56)
Affinity DataIC50:  2.40E+4nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent